Which Factors Are Associated With Comorbid Psychiatric Conditions in Patients Affected by Substance Use Disorders? The Impact of COVID-19 Pandemic on Dual-Diagnosis Subjects.

To investigate demographic/cinical variables associated to dual diagnosis and the psychological reaction of dual-diagnosis patients to COVID-19 pandemic. Information was collected at the Addiction Service of Monza, Italy. The Impact of Event Scale-Revised (IES-R), a self-report questionnaire measuri...

Descripción completa

Detalles Bibliográficos
Publicado en:Journal of Dual Diagnosis Vol. 20; no. 3; pp. 201 - 210
Autores principales: Tagliabue, Ilaria, Caldiroli, Alice, Capuzzi, Enrico, Borgonovo, Riccardo, Scalia, Alberto, Ferrè, Alessandro, Sibilla, Matteo, Turco, Marco, Affaticati, Letizia M., Crespi, Giovanna, Galimberti, Giovanni, Dakanalis, Antonios, Colmegna, Fabrizia, Buoli, Massimiliano, Clerici, Massimo
Formato: research tables/charts Journal Article
Publicado: Taylor & Francis Ltd Jul-Sep2024
Acceso en línea:Ver este registro en EBSCOhost
Descripción
Sumario:To investigate demographic/cinical variables associated to dual diagnosis and the psychological reaction of dual-diagnosis patients to COVID-19 pandemic. Information was collected at the Addiction Service of Monza, Italy. The Impact of Event Scale-Revised (IES-R), a self-report questionnaire measuring the subjective response to a traumatic event, was administered. Univariate analyses and binary logistic regression were performed. IES-R scores were compared between groups defined by qualitative variables through one-way analyses of variance (ANOVA). 118 outpatients were included, 48.3% with dual diagnosis. Alcohol use disorder and being female were associated to dual diagnosis. IES-R scores were significantly higher in the dual-diagnosis group, especially for personality disorders (PDs). IES-R scores were higher in patients taking treatment for substance use disorder (SUD). Females and alcohol abusers were at-risk subjects for dual diagnosis. Patients with SUD and PDs may benefit from additional support, especially when traumatic life events occur. ClinicalTrials.gov Identifier: NCT04694482